XML 22 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Redeemable convertible preferred stock
Redeemable preferred stock
Share capital
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Cumulative effect
Accumulated deficit
Cumulative effect
Total
Beginning balance at Dec. 31, 2017     $ 160 $ 12,339 $ 201   $ (28,792)   $ (16,092)
Beginning balance (in shares) at Dec. 31, 2017     15,960,468            
Beginning balance at Dec. 31, 2017 $ 154,800                
Beginning balance (in shares) at Dec. 31, 2017 111,452,020                
Exercise of options     $ 20 798         818
Exercise of options (in shares)     2,090,397            
Share-based compensation       6,919         6,919
Other comprehensive income (loss), net of tax         (920)       (920)
Net income (loss)             (7,189)   (7,189)
Ending balance at Dec. 31, 2018     $ 180 20,056 (719) $ 285 (35,981) $ 285 (16,464)
Ending balance (in shares) at Dec. 31, 2018     18,050,865            
Ending balance at Dec. 31, 2018 $ 154,800                
Ending balance (in shares) at Dec. 31, 2018 111,452,020                
Exercise of options     $ 20 1,024         1,044
Exercise of options (in shares)     1,932,934            
Share-based compensation       9,535         9,535
Other comprehensive income (loss), net of tax         862       862
Net income (loss)             (625)   (625)
Ending balance at Dec. 31, 2019     $ 200 30,615 143   (36,321)   $ (5,363)
Ending balance (in shares) at Dec. 31, 2019     19,983,799           19,983,799
Ending balance at Dec. 31, 2019 $ 154,800                
Ending balance (in shares) at Dec. 31, 2019 111,452,020 3,500              
Acquisition related issuance of common Stock     $ 28 15,515         $ 15,543
Acquisition related issuance of common Stock (in shares)     2,807,902            
Exercise of options     $ 7 221         228
Exercise of options (in shares)     420,416            
Share-based compensation       2,218         2,218
Other comprehensive income (loss), net of tax         (58)       (58)
Net income (loss)             (7,479)   (7,479)
Ending balance at Mar. 31, 2020 $ 154,800                
Ending balance (in shares) at Mar. 31, 2020 111,452,020                
Beginning balance at Dec. 31, 2019     $ 200 30,615 143   (36,321)   $ (5,363)
Beginning balance (in shares) at Dec. 31, 2019     19,983,799           19,983,799
Beginning balance at Dec. 31, 2019 $ 154,800                
Beginning balance (in shares) at Dec. 31, 2019 111,452,020 3,500              
Issuance of redeemable preferred stock and warrants       21,911         $ 21,911
Acquisition related issuance of common Stock     $ 28 15,515         15,543
Acquisition related issuance of common Stock (in shares)     2,807,902            
Exercise of options     $ 31 818         $ 849
Exercise of options (in shares)     3,063,712           3,313,666
Share-based compensation       11,074         $ 11,074
Other comprehensive income (loss), net of tax         4,031       4,031
Net income (loss)             (23,746)   (23,746)
Ending balance at Dec. 31, 2020     $ 259 79,933 4,174   (60,067)   $ 24,299
Ending balance (in shares) at Dec. 31, 2020     25,855,413           25,855,413
Ending balance at Dec. 31, 2020 $ 154,800 $ 10,735              
Ending balance (in shares) at Dec. 31, 2020 111,452,020 3,500              
Exercise of options     $ 5 464         $ 469
Exercise of options (in shares)     579,684            
Share-based compensation       $ 4,368         4,368
Other comprehensive income (loss), net of tax         $ (1,189)       (1,189)
Net income (loss)             $ (3,508)   $ (3,508)
Ending balance (in shares) at Mar. 31, 2021                 26,435,097
Ending balance at Mar. 31, 2021 $ 154,800 $ 10,735              
Ending balance (in shares) at Mar. 31, 2021 111,452,020 3,500